1. Home
  2. IBTA vs PHAR Comparison

IBTA vs PHAR Comparison

Compare IBTA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ibotta Inc.

IBTA

Ibotta Inc.

N/A

Current Price

$57.81

Market Cap

830.3M

Sector

N/A

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$13.07

Market Cap

793.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IBTA
PHAR
Founded
2011
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
830.3M
793.4M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
IBTA
PHAR
Price
$57.81
$13.07
Analyst Decision
Hold
Strong Buy
Analyst Count
9
4
Target Price
★ $50.57
$35.70
AVG Volume (30 Days)
★ 456.8K
15.1K
Earning Date
11-02-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $342,389,000.00
N/A
Revenue This Year
$7.08
$2.98
Revenue Next Year
$7.08
$8.95
P/E Ratio
★ N/A
$3,041.22
Revenue Growth
N/A
★ N/A
52 Week Low
$19.10
$9.11
52 Week High
$66.39
$21.34

Technical Indicators

Market Signals
Indicator
IBTA
PHAR
Relative Strength Index (RSI) 64.10 66.74
Support Level $36.20 $11.83
Resistance Level $66.39 $13.51
Average True Range (ATR) 3.70 0.49
MACD 0.16 0.10
Stochastic Oscillator 54.38 76.29

Price Performance

Historical Comparison
IBTA
PHAR

About IBTA Ibotta Inc.

Ibotta Inc operates a digital promotions platform, the Ibotta Performance Network (IPN), which connects consumer packaged goods (CPG) brands with consumers through a network of publishers. It sources digital offers from clients and distributes them via its technology platform, earning revenue when promotions result in consumer transactions. The platform supports offers across grocery and general merchandise categories, including toys, clothing, beauty, electronics, pet, and home products. The majority of its revenues is derived from the fees charged to clients when consumers redeem offers on the IPN by purchasing promoted products.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: